Responding to requests from adult patients for neuroenhancements: Guidance of the ethics, law and humanities committee

Neurology

Volumn 73, Issue 17, 2009, Pages 1406-1412

  Larriviere, Dan ^a   Williams, Michael A ^c   Rizzo, Matt ^d   Bonnie, Richard J ^b  

^a School Law   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c SINAI HOSPITAL OF BALTIMORE   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COGNITION; DOCTOR PATIENT RELATION; ETHICS; HEALTH CARE PERSONNEL; HUMAN; LEGAL ASPECT; MENTAL FUNCTION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; SOCIAL ASPECT;

ADULT; DRUG PRESCRIPTIONS; ETHICS, MEDICAL; HUMANS; LIABILITY, LEGAL; NOOTROPIC AGENTS;

EID: 70350560786     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181beecfe     Document Type: Article

References (44)

1. Farah MJ. Neuroethics: the practical and the philosophical. Trends Cogn Sci 2005;9:34-40.
2. McCabe SE, Teter CJ, Boyd CJ, Knight JR, Wechsler H. Nonmedical use of prescription opioids among U.S. college students: prevalence and correlates from a national survey. Addict Behav 2005;30:789-805.
3. McCabe SE, Teter CJ, Boyd CJ, Guthrie SK. Prevalence and correlates of illicit methylphenidate use among 8th, 10th, and 12th grade students in the United States, 2001. J Adolesc Health 2004;35:501-504.
4. Maher B. Poll results: look who?s doping. Nature 2008; 452:674-675.
5. Farah MJ, Illes J, Cook-Deegan R, et al. Neurocognitive enhancement: what can we do and what should we do? Nat Rev Neurosci 2004;5:421-425.
6. Chatterjee A. Cosmetic neurology: the controversy over enhancing movement, mentation, and mood. Neurology 2004;63:968-974.
7. Kass L. The President?s Council on Bioethics. Beyond Therapy: Biotechnology and the Pursuit of Happiness. Washington, DC: The President?s Council on Bioethics; 2003.
8. Greely H, Sahakian B, Harris J, et al. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 2008;456:702-705.
9. Yesavage JA, Mumenthaler MS, Taylor JL, et al. Donepezil and flight simulator performance: effects on retention of complex skills. Neurology 2002;59:123-125.
10. Gron G, Kirstein M, Thielscher A, Riepe MW, Spitzer M. Cholinergic enhancement of episodic memory in healthy young adults. Psychopharmacology 2005;182: 170-179.
11. Mehta MA, Owen AM, Sahakian BJ, Mavaddat N, Pickard JD, Robbins TW. Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci 2000; 20:RC65.
12. Elliott R, Sahakian BJ, Matthews K, Bannerjea A, Rimmer J, Robbins TW. Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology 1997;131:196-206.
13. Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ. Relative lack of cognitive effects of methyl-phenidate in elderly male volunteers. Psychopharmacology 2003;168:455-464.
14. Lynch G. Memory enhancement: the search for mechanism-based drugs. Nat Neurosci 2002;5 suppl:1035-1038.
15. de Jongh R, Bolt I, Schermer M, Olivier B. Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. Neurosci Biobehav Rev 2008;32:760-776.
16. American Academy of Neurology. Code of Professional Conduct, Sect 1.3. St. Paul: American Academy of Neurology; 2008.
17. Brody H, Miller FG. The internal morality of medicine: explication and application to managed care. J Med Philos 1998;23:384-410.
18. Gawande A. When law and ethics collide: why physicians participate in executions. N Engl J Med 2006;354:1221-1229.
19. American Academy of Neurology. Code of Professional Conduct, Sect 7.4. St. Paul: American Academy of Neurology; 2008.
20. Bloche MG, Marks JH. Doctors and interrogators at Guantanamo Bay. N Engl J Med 2005;353:6-8.
21. Miller FG, Brody H, Chung KC. Cosmetic surgery and the internal morality of medicine. Camb Q Healthc Ethics 2000;9:353-364.
22. Food Drug and Cosmetic Act, Section 201 (g)(1)(C). Merck settles Vioxx litigation. Nat Rev Drug Discovery 2007;6:946-947.
23. Farah MJ. Emerging ethical issues in neuroscience. Nat Neurosci 2002;5:1123-1129.
24. USCA sec 360e(d) (1)(A).
25. CFR sec 314.50 -54, 807.92(a)(5), 807.100(b)(1)(1999).
26. Richardson v Miller, 44 S.W. 3d 1 (Tenn. Ct. App. 2000).
27. Richardson v Miller, 44 S.W. 3d 1 (Tenn. Ct. App. 2000), p. 13.
28. Beauchamp T.L., Childress J.F., Principles of Biomedical Ethics 6th ed. Oxford: Oxford University Press 2009.
29. McNutt RA. Shared medical decision making: problems, process, progress. JAMA 2004;292:2516-2518.
30. Volkow ND, Fowler JS, Logan J, et al. Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. JAMA 2009;301:1148-1154.
31. American Academy of Neurology. Code of Professional Conduct, Sect 5.2. St. Paul: American Academy of Neurology;
32. American Academy of Neurology. Code of Professional Conduct, Sect 5.3. St. Paul: American Academy of Neurology;
33. Carmichael ML. Liability of physicians or hospital in performing cosmetic surgery upon the face. A.L.R. (3d) 54; 1255 Sec 2[a](1973);54.
34. Zalazar v Vercimack, 633 N.E. 2d 1223 (Ill. App. 3rd Dist. 1993).
35. Gill DG. "Anything you can do, I can do bigger?" The ethics and equity of growth hormone for small normal children. Arch Dis Child 2006;91:270-272.
36. Mayes R, Bagwell C, Erkulwater J. ADHD and the rise in stimulant use among children. Harv Rev Psychiatry 2008; 16:151-166.
37. Responding to requests from adult patients for neuroenhancements: Guidance of the Ethics, Law and Humanities Committee
38. Dan Larriviere, Michael A. Williams, Matt Rizzo, Richard J. Bonnie and On behalf of the AAN Ethics, Law and Humanities Committee Neurology 2009;73;1406-1412; originally published online Sep 23, 2009; DOI: 10.1212/WNL.0b013e3181beecfe
39. Downloaded from www.neurology.org by GERRIT JAN KRAMER on October 27, 2009 This information is current as of October 27, 2009 Updated Information & Services including high-resolution figures, can be found at:
40. Supplementary Material Supplementary material can be found at: http://www.neurology.org/cgi/content/full/WNL.0b013e3181beecfe/DC1 Subspecialty CollectionsThis article, along with others on similar topics, appears in the following collection(s): All Clinical Neurology http://www.neurology.org/cgi/ collection/all-clinical-neurology
41. All Ethics in Neurology/Legal issues http://www.neurology.org/cgi/ collection/all-ethics-in-neurology-l egal-issues
42. Professional conduct and ethics http://www.neurology.org/cgi/collection/ professional-conduct-and-ethics
43. Permissions & Licensing Information about reproducing this article in parts (figures, tables) or in its entirety can be found online at:
44. Reprints Information about ordering reprints can be found online: http://www.neurology.org/misc/reprints.shtml